Metropolis Healthcare Limited Announces Earnings Results for the Quarter and Nine Months Ended December 31, 2020
February 10, 2021 at 05:52 am EST
Share
Metropolis Healthcare Limited announced earnings results for the quarter and nine months ended December 31, 2020. For the quarter, the company reported total income of INR 2,267.930 million compared to INR 1,746.946 million a year ago. profit for the period was INR 486.961 million compared to INR 322.984 million a year ago. Earnings per basic share was INR 9.56 compared to INR 6.44 a year ago. Earnings per diluted shared was INR 9.53 compared to INR 6.42 a year ago.
For the nine months, the company reported total income of INR 5,843.166 million compared to INR 5,057.486 million a year ago. profit for the period was INR 1,032.507 million compared to INR 822.953 million a year ago. Earnings per basic share was INR 20.31 compared to INR 16.40 a year ago. Earnings per diluted shared was INR 20.21 compared to INR 16.37 a year ago.
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.